中信證券資產管理有限公司增持國藥控股(01099)161萬股每股作價約20.88港元

智通財經

2024-12-05

智通財經APP獲悉，香港聯交所最新資料顯示，12月4日，中信證券資產管理有限公司增持國藥控股(01099)161萬股，每股作價20.8751港元，總金額約爲3360.89萬港元。增持後最新持股數目爲9414.44萬股，最新持股比例爲7.02%。

本交易涉及其他關聯方：中信證券-雲帆單一資產管理計劃。

補充資料：權益爲中信證券資產管理有限公司代其管理的全部資產管理計劃披露持有的國藥控股股份有限公司 - H股權益。

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2489043129"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2489043129\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/2489043129?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":false,"pubTime":"2024-12-05 19:02","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2489043129","market":"hk","top_or_hot":-1,"title":"中信證券資產管理有限公司增持國藥控股(01099)161萬股 每股作價約20.88港元","media":"智通財經","content":"<html><body><p>智通財經APP獲悉，香港聯交所最新資料顯示，12月4日，<a href=\"https://laohu8.com/S/600030\">中信證券</a>資產管理有限公司增持<a href=\"https://laohu8.com/S/01099\">國藥控股</a>(01099)161萬股，每股作價20.8751港元，總金額約爲3360.89萬港元。增持後最新持股數目爲9414.44萬股，最新持股比例爲7.02%。</p><p>本交易涉及其他關聯方：<a href=\"https://laohu8.com/S/06030\">中信證券</a>-雲帆單一資產管理計劃。</p><p>補充資料：權益爲中信證券資產管理有限公司代其管理的全部資產管理計劃披露持有的國藥控股股份有限公司 - H股權益。</p><p><img src=\"https://img.zhitongcaijing.com/image/20241205/1733396583992836.png\" title=\"1733396583992836.png\"/></p></body></html>","source":"stock_zhitongcaijing","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n<meta content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\" name=\"viewport\"/>\n<meta content=\"telephone=no,email=no,address=no\" name=\"format-detection\"/>\n<title>中信證券資產管理有限公司增持國藥控股(01099)161萬股 每股作價約20.88港元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n中信證券資產管理有限公司增持國藥控股(01099)161萬股 每股作價約20.88港元\n</h2>\n<h4 class=\"meta\">\n</h4><p class=\"head\">\n<strong class=\"h-name small\">智通財經</strong><span class=\"h-time small\">2024-12-05 19:02</span>\n</p>\n</header>\n<article>\n<p>智通財經APP獲悉，香港聯交所最新資料顯示，12月4日，<a href=\"https://laohu8.com/S/600030\">中信證券</a>資產管理有限公司增持<a href=\"https://laohu8.com/S/01099\">國藥控股</a>(01099)161萬股，每股作價20.8751港元，總金額約爲3360.89萬港元。增持後最新持股數目爲9414.44萬股，最新持股比例爲7.02%。</p><p>本交易涉及其他關聯方：<a href=\"https://laohu8.com/S/06030\">中信證券</a>-雲帆單一資產管理計劃。</p><p>補充資料：權益爲中信證券資產管理有限公司代其管理的全部資產管理計劃披露持有的國藥控股股份有限公司 - H股權益。</p><p><img src=\"https://img.zhitongcaijing.com/image/20241205/1733396583992836.png\" title=\"1733396583992836.png\"/></p>\n<div class=\"bt-text\">\n<p> 來源：<a href=\"http://www.zhitongcaijing.com/content/detail/1221000.html\">智通財經</a></p>\n<p>為提升您的閱讀體驗，我們對本頁面進行了排版優化</p>\n</div>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU1997245094.SGD","symbol_name":"安聯神州A股基金AT Acc SGD","start_time":0,"source_url":"http://www.zhitongcaijing.com/content/detail/1221000.html","article_id":"2489043129","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2489043129","pubTimestamp":1733396574,"columns":[],"sourceInfo":{"source_id":"stock_zhitongcaijing","name":"智通财经网"},"weMediaInfo":null,"summary":"智通財經APP獲悉，香港聯交所最新資料顯示，12月4日，中信證券資產管理有限公司增持國藥控股(01099)161萬股，每股作價20.8751港元，總金額約為3360.89萬港元。增持後最新持股數目為9414.44萬股，最新持股比例為7.02%。本交易涉及其他關聯方：中信證券-雲帆單一資產管理計劃。補充資料：權益為中信證券資產管理有限公司代其管理的全部資產管理計劃披露持有的國藥控股股份有限公司 - H股權益。","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"600030":"中信证券","LU1997245094.SGD":"安联神州A股基金AT Acc SGD","LU0640798160.USD":"EASTSPRING INVESTMENTS GLOBAL EMERGING MARKET DYNAMIC \"A\" (USD) ACC","LU1115378108.SGD":"Eastspring Investments - Global Emerging Markets Dynamic AS SGD","LU1064131003.USD":"FULLERTON LUX FUNDS - CHINA A EQUITIES \"A\" (USD) ACC","LU1720050803.USD":"安联全方位中国股票基金","LU1997245177.USD":"安联神洲A股基金","LU0405327148.USD":"ALLSPRING CHINA A FOCUS \"A\" (USD) ACC","LU0405327494.USD":"ALLSPRING CHINA A FOCUS \"I\" (USD) ACC","BK1229":"房地产经营公司","LU1794554557.SGD":"Allianz All China Equity AT Acc H2-SGD","BK1521":"挪威政府全球养老基金持仓","BK1542":"内地物业管理股","LU1328615791.USD":"FULLERTON LUX FUNDS - ALL CHINA EQUITIES \"I\" (USD) ACC","09983":"建业新生活","BK0196":"行业龙头","LU2495084118.USD":"ALLIANZ CHINA A-SHARES \"ATH\" (USDHDG) ACC","LU1064130708.USD":"FULLERTON LUX FUNDS - CHINA A EQUITIES \"I\" (USD) ACC","BK0012":"证金概念","BK0183":"MSCI概念","06030":"中信证券","BK1564":"中资券商股","01099":"国药控股","LU2148510915.USD":"FULLERTON LUX FUNDS - CHINA A EQUITIES \"R\" (USD) ACC","LU2289578879.USD":"ALLIANZ CHINA A OPPORTUNITIES \"AT\" (USD) ACC","BK0276":"资本市场","BK1258":"房地产运营公司","BK1516":"腾讯概念","BK1515":"抗疫概念","BK0188":"融资融券","BK1147":"投资银行业与经纪业","LU1997244956.HKD":"ALLIANZ CHINA A-SHARES \"AT\" (HKD) ACC A","BK1500":"做空集合股","BK1197":"保健护理产品经销商","BK0028":"国家队","BK1583":"高瓴概念"},"translate_title":"CITIC Securities Asset Management Co., Ltd. increased its holdings of 1.61 million shares of Sinopharm Holdings (01099) at a price of approximately HK $20.88 per share","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"600030":1,"06030":1,"09983":1,"01099":1},"content_text":"智通財經APP獲悉，香港聯交所最新資料顯示，12月4日，中信證券資產管理有限公司增持國藥控股(01099)161萬股，每股作價20.8751港元，總金額約為3360.89萬港元。增持後最新持股數目為9414.44萬股，最新持股比例為7.02%。本交易涉及其他關聯方：中信證券-雲帆單一資產管理計劃。補充資料：權益為中信證券資產管理有限公司代其管理的全部資產管理計劃披露持有的國藥控股股份有限公司 - H股權益。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding","news_rank":0,"symbols":[],"gpt_button":0}}}